How molecular testing can help (and hurt) in the workup of gliomas.
Abstract
Advances in genetics research have greatly expanded our ability to accurately diagnose gliomas and provide more useful prognostic information. Herein specific examples are used to show how high-yield targets such as EGFR, 1p/19q, IDH1/2, MGMT, and BRAF can expand the power of the surgical neuropathologist. To avoid errors, however, the significance and controversies associated with each test must be thoroughly understood.
我要评论
翻译外文期刊杂志的文章摘要，通过管理员审核者可获取相应积分
本期排行
- Increased IgG4+ cells in duode...
- When less is more for patients...
- Cervical histopathology variab...
- Laboratory diagnostic oversigh...
- Macrophage heterogeneity of cu...
- The influence of rapid onsite ...
- Risk-benefit analysis of sampl...
- NSCLC subtype prediction using...
- How molecular testing can help...
- Laboratory test utilization pr...
共0条评论